HSIC - Henry Schein, Inc.
| Previous Close | 75.37 |
| Open | 75.51 |
| Bid | 75.60 x 1000 |
| Ask | 75.63 x 800 |
| Day's Range | 75.01 - 75.86 |
| 52 Week Range | 64.75 - 89.72 |
| Volume | |
| Avg. Volume | 819,380 |
| Market Cap | 9.878B |
| Beta (5Y Monthly) | 0.79 |
| PE Ratio (TTM) | 21.36 |
| EPS (TTM) | 3.53 |
| Earnings Date | Jul 31, 2023 - Aug 04, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 84.00 |
Simply Wall St.At US$75.26, Is It Time To Put Henry Schein, Inc. (NASDAQ:HSIC) On Your Watch List?
Henry Schein, Inc. ( NASDAQ:HSIC ), might not be a large cap stock, but it received a lot of attention from a...
Business WireStanley M. Bergman Delivers Commencement Address at the University of North Carolina at Chapel Hill Adams School of Dentistry
MELVILLE, N.Y., May 17, 2023--Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein, Inc. (NASDAQ: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, delivered the commencement address on May 12, 2023, at the University of North Carolina at Chapel Hill Adams School of Dentistry.
Business WireHenry Schein to Participate in Three Investor Conferences
MELVILLE, N.Y., May 17, 2023--Henry Schein to participate in three investor conferences.
ZacksHere's Why Investors Should Retain Henry Schein (HSIC) for Now
Henry Schein (HSIC) is expected to witness a favorable share price movement, led by optimism surrounding the performance of the dental business and strategic buyouts.
- Thomson Reuters StreetEvents
Q1 2023 Henry Schein Inc Earnings Call
Q1 2023 Henry Schein Inc Earnings Call
ZacksHenry Schein (HSIC) Q1 Earnings Miss, Operating Margin Dips
Henry Schein's (HSIC) first-quarter results largely reflect lower contributions from the sales of PPE products and COVID-19 test kits.
ZacksHenry Schein (HSIC) Q1 Earnings and Revenues Miss Estimates
Henry Schein (HSIC) delivered earnings and revenue surprises of -2.42% and 1.13%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Business WireHenry Schein Reports First-Quarter 2023 Financial Results
MELVILLE, N.Y., May 09, 2023--Henry Schein reports first-quarter 2023 financial results.
ZacksWhy Earnings Season Could Be Great for Henry Schein (HSIC)
Henry Schein (HSIC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Business WireHenry Schein Acquires Regional Health Care Group, a Medical Distributor Serving the Australia and New Zealand Region
MELVILLE, N.Y., May 07, 2023--Henry Schein acquires Regional Health Care Group, a medical distributor serving the Australia and New Zealand region.
- Simply Wall St.
Henry Schein, Inc.'s (NASDAQ:HSIC) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
It is hard to get excited after looking at Henry Schein's (NASDAQ:HSIC) recent performance, when its stock has declined...
Business WireHenry Schein Signs Definitive Agreement to Acquire S.I.N. Implant System
MELVILLE, N.Y., May 04, 2023--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care products and services to office-based dental and medical practitioners, announced an agreement to acquire S.I.N. Implant System, one of Brazil’s leading manufacturers of dental implants, pending regulatory approval.
ZacksHenry Schein (HSIC) Stock Moves -0.58%: What You Should Know
Henry Schein (HSIC) closed the most recent trading day at $80.01, moving -0.58% from the previous trading session.
ZacksWhy Henry Schein (HSIC) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Business WireHenry Schein Dental Presents: THRIVELIVE 2023
MELVILLE, N.Y., May 03, 2023--Henry Schein Dental Presents: THRIVELIVE 2023
ZacksHenry Schein (HSIC) Stock Sinks As Market Gains: What You Should Know
Henry Schein (HSIC) closed at $81.19 in the latest trading session, marking a -0.02% move from the prior day.
ZacksQuest Diagnostics (DGX) Q1 Earnings Top Estimates, Margins Down
Quest Diagnostics (DGX) base business registers growth in the first quarter of 2023.
ZacksIntegra's (IART) Q1 Earnings Match Estimates, Margins Contract
In CSS, Integra (IART) witnesses a good start to the year with double-digit growth in the CUSA product line and programmable valves as well as strong performance in instrument sales.
ZacksThe Zacks Analyst Blog Highlights BioRad Laboratories, Henry Schein, Insulet, Abbott and LabCorp
BioRad Laboratories, Henry Schein, Insulet, Abbott and LabCorp are included in this Analyst Blog.
ZacksZacks Industry Outlook Highlights West Pharmaceutical Services, The Cooper Companies and Henry Schein
West Pharmaceutical Services, The Cooper Companies and Henry Schein have been highlighted in this Industry Outlook article.
ZacksBoston Scientific (BSX) Q1 Earnings Beat, 2023 View Raised
Reported and organic revenues at each of Boston Scientific's (BSX) core business segments and geographies increase in the reported quarter.
ZacksThermo Fisher (TMO) Q1 Earnings Beat Estimates, Margins Down
The year-over-year growth in the Analytical Instruments and the Laboratory Products and Biopharma Services segments drove Thermo Fisher's (TMO) Q1 revenues.
- Zacks
3 Dental Supplies Stocks to Buy as Industry Prospects Recover
Here, we discuss three stocks from the Dental Supplies industry that are likely to create wealth for investors. These include WST, COO and HSIC.
ZacksIllumina (ILMN) Q1 Earnings Beat Estimates, Margins Contract
Illumina's (ILMN) Q1 revenues decline year over year, reflecting the impact of Covid-19 monitoring headwinds and the transition of its high-throughput customers to NovaSeq X.
Zacks3 MedTech Stocks Likely to Beat Estimates in Q1 Earnings
MedTech companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how BIO, HSIC and PODD are poised ahead of their earnings releases.
